SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-086654
Filing Date
2024-04-04
Accepted
2024-04-04 08:25:38
Documents
6
Effectiveness Date
2024-04-04

Document Format Files

Seq Description Document Type Size
1 S-8 d821390ds8.htm S-8 35729
2 EX-5.1 d821390dex51.htm EX-5.1 54784
3 EX-23.1 d821390dex231.htm EX-23.1 1197
4 EX-FILING FEES d821390dexfilingfees.htm EX-FILING FEES 19017
5 GRAPHIC g821390g0402221319620.jpg GRAPHIC 2771
6 GRAPHIC g821390g0402221319775.jpg GRAPHIC 2474
  Complete submission text file 0001193125-24-086654.txt   119420
Mailing Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW 44 (0)20 8154 4600
Achilles Therapeutics plc (Filer) CIK: 0001830749 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278501 | Film No.: 24821714
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)